Pathophysiology of cancer therapy-provoked atrial fibrillation

Wan Li Cheng, Yu Hsun Kao, Shih Ann Chen, Yi Jen Chen

Research output: Contribution to journalReview articlepeer-review

28 Citations (Scopus)


Atrial fibrillation (AF) occurs with increased frequency in cancer patients, especially in patients who undergo surgery or chemotherapy. AF disturbs the prognosis of cancer patients and challenges therapeutic outcomes of cancer treatment. Elucidating the mechanisms of cancer-induced AF would help identify specific strategies for preventing AF occurrence. In addition to concurrent risk factors of cancer and AF, cancer surgery, side effects of anticancer agents, and cancer-associated immune responses play critical roles in the genesis of AF. In this review, we provide succinct potential mechanisms of AF genesis in cancer patients.

Original languageEnglish
Pages (from-to)186-194
Number of pages9
JournalInternational Journal of Cardiology
Publication statusPublished - Sept 15 2016


  • Atrial fibrillation
  • Cancer surgery
  • Chemotherapy
  • Proinflammatory cytokines

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Pathophysiology of cancer therapy-provoked atrial fibrillation'. Together they form a unique fingerprint.

Cite this